DADaria Akimova

Daria Akimova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daria Akimova has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Case Report: A novel deep intronic MFSD8 splice-altering variant causes CLN7 disease through pseudoexon inclusion

    by Daria Akimova, Anait Voskanyan, Anna Orlova, Mikhail Skoblov

    Pathogenic deep intronic variants are an underrecognized cause of inherited disorders because they are typically missed by exon-focused sequencing and often require functional validation. We describe a patient with classic CLN7 disease caused by a previously unreported deep intronic variant in MFSD8 . The patient presented with developmental regression, progressive epilepsy, cerebellar ataxia, and cerebral and cerebellar atrophy. Trio whole-genome sequencing identified a homozygous MFSD8 variant, NM_001371596.2:c.999-556C>G, absent from population databases and previous reports. SpliceAI predicted activation of cryptic splice sites leading to inclusion of a 98-nt pseudoexon. RNA analysis of patient-derived fibroblasts confirmed aberrant pseudoexon inclusion, resulting in a frameshift and premature termination codon, with the aberrant transcript accounting for 84% of total MFSD8 transcripts. A minigene assay independently reproduced the splicing defect, confirming that the variant disrupts normal MFSD8 splicing. This study expands the mutational spectrum of MFSD8 and provides functional evidence supporting the pathogenicity of a novel deep intronic splice-altering variant. Our findings further demonstrate the value of combining whole-genome sequencing with transcript analysis for the molecular diagnosis of unsolved rare neurogenetic disorders.

  • Open Access

    PDXK ‐Related Neuropathy: A Case With a Novel Splice‐Altering Missense Variant and Literature Review

    by Dmitrii Subbotin, Daria Akimova, Elena Dadali, Kristina Mikhalchuk, Artem Borovikov, Vitaly Kadyshev, Mikhail Skoblov, Aysylu Murtazina

    Background: PDXK ‐related neuropathy is a rare form of hereditary motor and sensory neuropathy with optic atrophy, caused by biallelic variants in the PDXK gene. To date, only four missense variants have been reported in 13 patients from six families. Unlike most inherited neuropathies, which currently have only symptomatic treatments, this type of neuropathy can be managed with pyridoxal 5′‐phosphate supplementation. Methods: The clinical presentation of the patient was evaluated twice, at ages 14 and 15 years. The whole‐exome sequencing was performed for the proband followed by functional studies using RNA extracted from the proband's and proband's mother's peripheral blood mononuclear cells. Results: In this study, we provided a brief literature review on PDXK ‐related neuropathy and reported a female patient with a novel missense variant (c.826G>C, p.(Ala276Pro)) found in compound heterozygous state with a previously reported variant (c.659G>A, p.[Arg220Gln]) in the PDXK gene. Additionally, she carried a novel likely pathogenic missense variant (c.1180C>T, p.[Arg394Cys]) in the GCK gene, associated with MODY2, which was segregated with hyperglycemia in her family. The novel variant c.826G>C in the PDXK gene was predicted to disrupt splicing that was confirmed by our functional studies. The patient exhibited typical peripheral neuropathy but no optic atrophy, likely due to her young age. Conclusions: Here we report a novel splice‐altering missense variant in PDXK that induces aberrant transcript degradation, revealing a new disease mechanism for PDXK ‐related neuropathy.

  • Open Access

    Case Report: Dual pathogenic mechanism of a PRKG2 missense variant underlies an attenuated phenotype of acromesomelic dysplasia

    by Daria Akimova, Tatiana Markova, Maria Orlova, Vladimir Kenis, Mikhail Skoblov

    Acromesomelic dysplasia comprises a group of rare skeletal disorders characterized by dwarfism with anomalies predominantly affecting the middle and distal segments of the limbs. Based on genetic variants, five types are recognized, with significant phenotypic variability even within a single type. Here, we describe a girl presenting with borderline short stature and mild disproportion due to acro- and mesomelic shortening of the limbs. Radiographic examination revealed shortening of the radius and ulna, mild brachydactyly, absence of iliac flaring and metaphyseal alterations of the long bones, and biconcave appearance of the femoral necks and II-IV metacarpals, and an elongated styloid process of the ulna. Using WGS, we identified two novel variants in the PRKG2 gene: a frameshift variant (NM_006259.3:c.1074del (p.Ala359LeufsTer24)) and a missense variant (NM_006259.3:c.1630G>T (p.Asp544Tyr)). Functional analysis unveiled a unique dual pathogenic mechanism: the missense variant creates a cryptic splice site, resulting in two aberrant protein products - an in-frame deletion and a missense substitution. We hypothesize that these alterations cause a partial, rather than a complete, loss of protein function, which may account for the patient’s attenuated clinical phenotype.

  • Genomic imprinting disorders in the structure of syndromic obesity in children

    by O. V. Vasyukova, E. P. Atavina-Ermakova, E. G. Panchenko, D. A. Kopytina, O. A. Simonova, V. Y. Udalova, I. V. Kanivets, D. B. Akimova, M. Y. Skoblov, M. A. Andreeva, et al.

    BACKGROUND . Genomic imprinting disorders represent a distinct class of hereditary diseases caused by disruption of the monoallelic expression of imprinted genes. Several of them are closely associated with obesity and metabolic disturbances. Syndromes such as Prader–Willi, Angelman, Schaaf–Yang, Temple, and pseudohypoparathyroidism types 1a and 1b illustrate how dysregulation of imprinted gene expression can lead to energy imbalance, hyperphagia, reduced physical activity, and abnormal fat distribution. Currently, the proportion of early-onset and severe obesity cases caused by genetic factors is steadily increasing. AIM . To study the clinical and genetic characteristics of syndromic forms of obesity in children. MATERIALS AND METHODS . A retrospective non-comparative study. The study included 186 patients who were examined at the Endocrinology Research Center with suspected genetic forms of obesity in the period from October 2022 to May 2025. RESULTS . Genomic imprinting disorders were confirmed in 12% of patients (n=22), including: Prader–Willi syndrome (n=12), Angelman syndrome (n=1), Schaaf–Yang syndrome (n=1), Temple syndrome (n=1), multilocus imprinting disturbances (MLID) (n=1), and pseudohypoparathyroidism type 1a (n=6). At the time of examination: 13.6% (n=3) had overweight (BMI SDS 1.0–1.9 SD), 4.6% (n=1) had grade 1 obesity (BMI SDS 2.0–2.4 SD), 18.2% (n=4) had grade 3 obesity (BMI SDS 3.0–3.9 SD), and 40.9% (n=9) had morbid obesity (BMI SDS≥4.0 SD). Excessive weight gain during the first year of life was observed in 40.9% (n=9), and in 31.8% (n=7) starting from the second year of life. Clinical signs of hyperphagia were identified in 54.5% of cases (n=12). A positive family history of obesity was identified in 31.8% of cases (n=7). The median BMI SDS was 3.71 SD [1.8025; 4.2875]. Obesity- and overweight-related complications were observed in 13 out of 17 patients. CONCLUSION . The study presents the genetic and clinical characteristics of genomic imprinting disorders within the structure of syndromic obesity in children in the Russian Federation.

  • Open Access

    De Novo HNRNPU Pathogenic Variant Related to Developmental Epileptic Encephalopathy With Inherited KANSL1 Loss‐of‐Function Variant Resolved by RNA Analysis

    by Daria Akimova, Daria Guseva, Maria Nefedova, Mikhail Skoblov

    Background: Developmental and epileptic encephalopathies (DEEs) comprise a diverse range of disorders that can arise from both genetic and non‐genetic causes. Genetic DEEs are linked to pathogenic variants in various genes with different molecular functions. The wide clinical and genetic variability found in DEEs poses a considerable challenge for accurate diagnosis even with the use of comprehensive diagnostic approaches such as whole genome sequencing (WGS).Case Presentation: In this study, we describe a girl with a clinical presentation of DEE. Using WGS, we identified several candidate variants in the HNRNPU, NIPBL, and KANSL1 genes with partial overlap with the patient's clinical presentation. Subsequent analysis revealed that only the variant in the HNRNPU gene arose de novo, while the others were inherited from unaffected parents. The variant in HNRNPU was determined to be causative. However, the previously reported pathogenic loss‐of‐function (LoF) variant in KANSL1, inherited from a healthy mother, complicated the interpretation of the results. A thorough investigation using RNA analysis showed that the variant in the KANSL1 gene is located in a duplicated locus, which does not produce a functional protein, explaining the lack of the variant's contribution to the development of the pathological phenotype.Conclusions: This case illustrates the importance of integrating WGS with additional analyses to accurately diagnose and understand the molecular basis of the lack of influence of the LoF variant in KANSL1 on the patient's phenotype.

  • Open Access

    RNA Analysis Uncovers Pathogenic PARN Variant in Dyskeratosis Congenita

    by Daria Akimova, Natalia Semenova, Tatiana Cherevatova, Mikhail Skoblov

    Dyskeratosis congenita (DC) is a rare genetic disorder caused by impaired telomere maintenance, leading to diverse clinical manifestations, including bone marrow failure, mucocutaneous abnormalities, and multi‐organ dysfunction. Here, we report a 14‐year‐old male patient presenting with microcephaly, developmental delay, synostoses, cerebellar hypoplasia with ataxia, and an immunodeficiency condition, but lacking classical DC features such as nail dystrophy and skin hyperpigmentation. WGS revealed two variants in the PARN gene: a known pathogenic missense variant (c.1045C > T, p.Arg349Trp) and a novel intronic variant (c.178‐28T > C). Functional RNA analysis demonstrated that the intronic variant disrupts the branch point sequence, leading to exon 4 skipping and nonsense‐mediated decay (NMD) of a significant proportion of transcripts. This study confirms the pathogenicity of the intronic variant and underscores the importance of functional validation in interpreting noncoding variants, particularly in genetically heterogeneous disorders like DC. Our findings expand the molecular and phenotypic spectrum of PARN ‐related DC and highlight the utility of WGS reanalysis and RNA studies in resolving diagnostically challenging cases.


  • Open Access

    Beyond the Known: Expanding the Clinical and Genetic Spectrum of Rare RPL13-Related Spondyloepimetaphyseal Dysplasia

    by Daria Gorodilova, Elena Dadali, Vladimir Kenis, Evgenii Melchenko, Daria Akimova, Maria Bulakh, Anna Orlova, Maria Orlova, Olga Shatokhina, Evgeniya Melnik, et al.

    Spondyloepimetaphyseal dysplasia type Isidor-Toutain (RPL13-SEMD) is an autosomal dominant skeletal dysplasia caused by heterozygous pathogenic variants in the RPL13 gene, encoding the ribosomal protein eL13. To date, 13 pathogenic variants in RPL13 have been reported, all clustering within intron 5 and exon 6, suggesting this hotspot region is critical for the function of ribosomes in skeletal tissues. Here, we present clinical and radiological characteristics of seven individuals, five children and two adults, from four unrelated families with RPL13-SEMD caused by two novel variants (c.477+5G>C and c.539_541del) and two previously reported variants (c.477+1G>C and c.548G>A) in RPL13. RNA analysis demonstrated that c.477+5G>C leads to a 54-nucleotide extension of exon 5, resulting in an 18-amino acid insertion. The phenotypic spectrum ranged from mild manifestations, such as Blount-like tibial deformity without significant short stature or Perthes-like femoral epiphyseal changes, to severe skeletal deformities with disproportionate short stature, accompanied by extraskeletal features (e.g., penoscrotal hypospadias, coccygeal abnormalities). For the first time, we describe Blount-like tibial deformity as a feature of this dysplasia, which resolves with age. Our study provides additional insights into the clinical, radiological, and genotypic features of RPL13-SEMD through detailed analysis of patients and their affected relatives.


  • Open Access

    Molecular and Clinical Aspects of Osteogenesis Imperfecta Type VI: A Case Series with Novel SERPINF1 Gene Variants

    by Elena S. Merkuryeva, Tatyana S. Nagornova, Vladimir M. Kenis, Anna S. Deviataikina, Daria B. Akimova, Dmitry S. Buklaev, Ilya S. Dantsev, Aisluu O. Dulush, Ekaterina Y. Zakharova, Tatiana V. Markova

    Osteogenesis imperfecta type VI is a rare autosomal recessive disorder characterized by bone fragility and defective mineralization, caused by pathogenic variants in the SERPINF1 gene. This study aimed to expand the understanding of OI type VI by analyzing clinical, radiological, and molecular findings in four patients from three unrelated families. Genotyping revealed two novel SERPINF1 variants, c.185G>T (p.Gly62Val) and c.992_993insCA (p.Glu331Asnfs), in a compound heterozygous state in one patient, and a known pathogenic variant, c.261_265dup (p.Leu89Argfs26), in a homozygous form in three patients. Clinical manifestations included early-onset fractures, severe skeletal deformities, impaired mobility, and growth failure. Radiological assessments revealed multilevel and multiplanar bone deformities and metaphyseal widening. RNA analysis demonstrated that the c.992_993insCA variant results in a truncated PEDF protein without triggering nonsense-mediated decay. Population screening identified a carrier frequency of 0.0044 for the c.261_265dup variant, suggesting a founder effect in the Tuvinian population. These findings expand the mutational spectrum of the SERPINF1 gene and provide new insights into the phenotypic variability of OI type VI. Our results highlight the importance of genetic screening in isolated populations and emphasize the need for further research to develop more effective therapeutic approaches for patients with limited response to bisphosphonate therapy.


  • Open Access

    Variable clinical presentation of split hand/foot malformation syndrome in a family with microduplication of 10q24.32: a case report

    by Daria Akimova, Tatiana Markova, Maria Ampleeva, Mikhail Skoblov

    SHFM (Split Hand/Foot Malformation) is a heterogeneous group of disorders characterized by the presence of clefts in the hands and feet, along with syndactyly of the digits. In this article, we describe a family in which two members exhibit characteristic developmental abnormalities associated with SHFM, presenting with variable clinical features. Using whole-genome sequencing, we identified a microduplication of a chromosomal segment on locus 10q24.32, specifically spanning positions 102934495 to 103496555, encompassing genes BTRC, POLL, FBXW4 and LBX1 in the proband. Genomic duplications, including these genes, were previously described in patients diagnosed with the third type of SHFM. We validated the presence of this structural rearrangement in 7 family members, including the proband and the proband’s father. Remarkably, further investigation demonstrated that the detected duplication exhibits a mosaic state in the phenotypically normal paternal grandmother of the proband, thereby providing a plausible explanation for the absence of a pathological phenotype in her.